In a patient with recent increased bowel movements and diarrhea over the past 24–48 hours, who has multiple palpable subcutaneous masses (1–4 cm) not visible on the skin, normal complete blood count (CBC) and comprehensive metabolic panel (CMP) except a mildly elevated free triiodothyronine (free T3), is the diarrhea clinically relevant, and what are the top three to five most likely diagnoses with their estimated likelihoods and prognoses?

Clinical Relevance and Differential Diagnosis

Yes, the diarrhea is clinically relevant and, combined with the mildly elevated free T3 and multiple subcutaneous masses, strongly suggests thyrotoxicosis as the primary diagnosis, with hematologic malignancy as a critical alternative consideration.

Why This Matters

The combination of recent-onset diarrhea (24-48 hours) with elevated free T3 creates a compelling clinical picture. Diarrhea is a well-established manifestation of thyrotoxicosis, occurring through increased gastrointestinal motility from excess thyroid hormone 1, 2. The British Society of Gastroenterology guidelines explicitly identify thyrotoxicosis as a systemic disease predisposing to diarrhea through endocrine effects 2.

The subcutaneous masses add diagnostic complexity. While not visible on skin surface but palpable (1-4 cm), these could represent thyroid-related nodular disease or, more concerning, cutaneous/subcutaneous involvement by hematologic malignancy.

Top Differential Diagnoses with Likelihood Estimates

1. T3 Thyrotoxicosis (Probability: 60-70%)

This is the most likely diagnosis given the elevated free T3 with recent diarrhea onset. T3 thyrotoxicosis represents early-stage hyperthyroidism or autonomous thyroid nodule function 1, 3. The presence of palpable masses (1-4 cm) could represent multinodular goiter or autonomous nodules.

Key diagnostic features:

• Suppressed TSH with normal or mildly elevated free T3 1, 4
• Diarrhea occurs in 43-85% of newly diagnosed hyperthyroidism 2
• Palpable thyroid nodules are consistent with autonomous function 3

Prognosis: Excellent with treatment. Radioactive iodine or surgery typically reverses TSH suppression 3. Untreated thyrotoxicosis can progress to weight loss, osteoporosis, atrial fibrillation, and cardiovascular collapse 1.

Critical caveat: Confirm TSH is suppressed (<0.01 mU/L for highest diagnostic yield) 4, 3. If TSH is normal, this diagnosis is essentially excluded 1.

2. Hematologic Malignancy with Cutaneous/Subcutaneous Involvement (Probability: 20-25%)

This must be urgently excluded given multiple palpable subcutaneous masses. Leukemia, lymphoma, and multiple myeloma can present with subcutaneous infiltration 5.

Key diagnostic features:

• Multiple lesions (as in this case) are typical 5
• Subcutaneous fat infiltration on ultrasound 5
• Hypoechoic foci within hyperechoic background with abundant vascularity 5
• Normal CBC/CMP does NOT exclude this—early disease or specific subtypes may have normal counts

Prognosis: Highly variable depending on specific malignancy type and stage. Cutaneous involvement generally indicates advanced disease with poorer prognosis, but some lymphomas are highly treatable.

Critical action: The ultrasound finding of one mass with negative CT for masses is concerning. Ultrasound is superior for subcutaneous lesions 5, 6. Biopsy of at least one mass is mandatory to exclude malignancy.

3. Multinodular Goiter with Subclinical Hyperthyroidism (Probability: 10-15%)

Similar to T3 thyrotoxicosis but represents earlier/milder disease. All six patients with subclinical hyperthyroidism or T3 toxicosis in one study had either multinodular glands or single nodules 3.

Prognosis: Generally good, though may progress to overt hyperthyroidism. Treatment decisions depend on symptoms and cardiovascular risk.

4. Infectious Gastroenteritis (Coincidental) with Unrelated Subcutaneous Lesions (Probability: 3-5%)

Acute diarrhea (24-48 hours) is more consistent with infectious etiology than chronic causes. However, the elevated free T3 makes this less likely as the sole explanation.

Prognosis: Self-limited if infectious, but doesn't explain the masses or thyroid abnormality.

5. Lipomas or Benign Subcutaneous Masses with Coincidental Thyroid Abnormality (Probability: 1-2%)

Multiple lipomas are common and benign 6, but the constellation of findings makes this unlikely.

Prognosis: Excellent if confirmed benign.

Immediate Diagnostic Algorithm

Step 1: Measure TSH immediately

• If TSH <0.01 mU/L: Confirms thyrotoxicosis; proceed to thyroid scan/uptake 3
• If TSH normal: Thyrotoxicosis excluded; focus on masses 1

Step 2: Biopsy at least one subcutaneous mass

• Essential to exclude hematologic malignancy 5
• Cannot rely on negative CT—ultrasound is superior for subcutaneous lesions 6

Step 3: If TSH suppressed, obtain:

• Total T3 to confirm elevation 3, 7
• Thyroid scan with radioactive iodine uptake to identify autonomous function 3

Step 4: Stool studies only if diarrhea persists beyond 1 week or if TSH/masses workup is unrevealing 2

Critical Pitfalls to Avoid

1. Do not dismiss mildly elevated free T3 as insignificant—this may represent early T3 thyrotoxicosis 1, 4, 3

2. Do not assume normal CBC/CMP excludes hematologic malignancy—cutaneous involvement can occur with normal counts 5

3. Do not rely solely on CT for subcutaneous masses—ultrasound and MRI are superior 5, 6

4. Check for biotin supplementation—high-dose biotin (>5 mg/day) causes falsely elevated thyroid hormones on immunoassays 8. Stop biotin 72 hours before retesting if suspected.

5. The 24-48 hour timeframe is too short to meet chronic diarrhea criteria (≥4 weeks) 2, but combined with elevated T3, it represents an acute manifestation of thyrotoxicosis rather than chronic diarrhea requiring extensive GI workup.